Keywords: Stada, Pfizer, OSI Pharmaceuticals, Astellas

M&A update: Stada looks up for sales; OSI lets Astellas see confidential data

Article | 31 March 2010

Print This

In two pieces of M&A related news, German generic drugmaker Stada has revealed that it would be open ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in